MDL-28842

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMDL-28842

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAdenosylhomocysteinase inhibitors

TargetsAdenosylhomocysteinase

Therapy Area/IndicationsArthritis, RheumatoidNeoplasmsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis

Active IndicationsN/A

Inactive IndicationsArthritis, RheumatoidNeoplasmsMalaria

ATC CodeN/A